Investigation of Environmental Parameters in Operating Rooms

NCT ID: NCT05816135

Last Updated: 2023-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative surgical site infection (SSI) is a serious and complicated healthcare-associated infection (HAI) affecting about 2% of patients undergoing orthopedic surgery. Exogenous infections, could occur from insufficient air quality in operating rooms as shown in previous studies. However, from our knowledge, no study have collect environmental parameters and cross referenced the data with recorded patient registries to see if insufficient air quality is associated with higher risk of exogenous SSI. Temperature, humidity and the difference in air pressure in relation to the operating room and the adjacent corridors are examples of environmental parameters that could affect the air quality in operating rooms. Number of persons during an operation and particle counts could also give an indication of insufficient air quality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative surgical site infection (SSI) is a serious and complicated healthcare-associated infection (HAI) affecting about 2% of patients undergoing orthopedic surgery. The source of the SSI can be the patient's own bacteria, which have entered the wound e.g. via the bloodstream or the skin, giving rise to so called endogenous infection. Exogenous infection is instead when the wound is contaminated from an external source, e.g. from skin particles shredded from the operating personnel or from other airborne bacterial- containing particles that end up directly in the wound of the patient. The particles can also fall on surfaces causing indirect wound contamination via surgical instruments or via the surgeon's hands. The consequences of SSI are usually greatest when a foreign body, such as an implant, has been placed into the patient's body. The foreign material gives the bacteria a surface to attach to and to form biofilm on, which protects the bacteria against both the body's immune system and antibiotic treatment.

In 2019, approximately 19,000 hip prostheses and 15,000 knee prostheses surgeries were performed in Sweden. The consequences of a prosthetic infection for the patient include longer care and rehabilitation time, long-term pain, risk of reoperation, and increased mortality. An especially vulnerable group is the elderly, fragile patients, who are more susceptible to getting an infection and are most likely to have a mortal outcome.

SSI after orthopedic implant-related surgery also has economic consequences for the healthcare, with an extra cost of 0.5-1 MSEK/deep infection. Based on these socio-economic and humane reasons, there is a great need to prevent SSI. Another reason is the increasing development of antibiotic resistance, which threatens the possibilities of effectively preventing and treating SSI.

Airborne contamination is considered a very important exogenous source of infection. In a land-mark study from 1982 it was showed that ultraclean air in operating rooms (\< 10 bacteria-carrying particles (CFU)/m3) reduced the incidence of deep sepsis by 1/3 after total joint-replacement operations compared with control- operating rooms. In addition, there was a substantial reduction in the mean numbers of bacteria isolated from wounds during operations performed under ultraclean-air conditions compared with those isolated from wounds during operations in the control rooms.

In a previous study, we are addressing the issue of possible relationship between air contamination - measured as colony forming units (CFU)/m3, bacteria present in the wound, and the occurrence of SSI. In the study, the bacteriological findings and the incidence of SSI are evaluated in relation to conventional ventilated operating rooms and conventional ventilated operating rooms with the addition of local clean airflow over the surgical instruments. Because particles in the air act as means of transportation for bacteria, there is a consensus that the risk of bacterial airborne infection can be prevented by keeping particle levels as low as possible in the operating room. The most obvious way of controlling the number of particles in the air is via ventilation. The most common types of ventilation in an operating room today is mixed ventilation (also called displaced or conventional ventilation) or vertical laminar airflow (LAF). However, both these systems are very sensitive to disturbances of the airflow caused by e.g. door openings, the number of staff working inside the room and their movements and obstructive objects, as shown in previous studies.

The golden standard of microbial surveillance today is via measuring CFU during on going surgery. This gives a good estimation of bacteria in the operating room. However, the method is time and resource consuming, and requires handling of microbial sampling and incubation. As incubation takes approximately 2 days, the results are delivered to late before any intervention could be made. Particle counting could be used as a proxy-unit instead of CFU to give an indication of microbial presence in real-time. However, the association between CFU and particles must be investigated further for such an assumption to be made.

Environmental factors such as temperature, humidity and the difference in air pressure in relation to the operating room and the adjacent corridors also affect the air quality in operating rooms. The significance of these factors for bacterial airborne infection is, so far, relatively unknown and unexplored field of research and therefore of interest to investigate further.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Site Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Orthopedic implant related surgery
* Surgery in operating rooms with installed equipment

Exclusion Criteria

* Non-implant related surgery
* No Swedish citizen (no personal-id number)
* Revision surgery due to infection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Getinge Group

OTHER

Sponsor Role collaborator

Sahlgrenska University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maziar Mohaddes Ardebili

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maziar Mohaddes, PhD

Role: PRINCIPAL_INVESTIGATOR

Sahlgrenska University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sahlgrenska University Hospital

Gothenburg, Västra Götaland County, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Henrik Malchau, PhD

Role: CONTACT

708207651 ext. +46

Frans Stålfelt, McS

Role: CONTACT

0730317678

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Getinge study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Germicidal Light
NCT03886337 WITHDRAWN NA
Operating Room Air Filtration/Sterilization
NCT04610294 ACTIVE_NOT_RECRUITING NA